{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:55:43Z","timestamp":1767833743815,"version":"3.49.0"},"reference-count":18,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,18]]},"DOI":"10.20945\/2359-3997000000530","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T12:51:31Z","timestamp":1674132691000},"source":"Crossref","is-referenced-by-count":2,"title":["Iodine nutritional status is not a direct factor in the prevalence of the BRAFV600E mutation in papillary thyroid cancer"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5692-5446","authenticated-orcid":false,"given":"Yan-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-3819","authenticated-orcid":false,"given":"Yu-Shan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"key":"key20230119065455_B1","volume-title":"A review of the nutrition situation in Vietnam 2009-2010","author":"UNICEF","year":"2011","unstructured":"UNICEF. A review of the nutrition situation in Vietnam 2009-2010. Hanoi, Vietnam: UNICEF; 2011."},{"issue":"2","key":"key20230119065455_B2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00394-016-1370-2","article-title":"Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area","volume":"57","author":"Kim","year":"2018","unstructured":"Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK, et al. Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area. Eur J Nutr. 2018;57(2):809-15.","journal-title":"Eur J Nutr"},{"issue":"4","key":"key20230119065455_B3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(92)90164-7","article-title":"Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity","volume":"93","author":"Belfiore","year":"1992","unstructured":"Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4):363-9.","journal-title":"Am J Med"},{"issue":"4","key":"key20230119065455_B4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2265.2005.02367.x","article-title":"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan","volume":"63","author":"Liu","year":"2005","unstructured":"Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, et al. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clin Endocrinol (Oxf). 2005;63(4):461-6.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20230119065455_B5","article-title":"The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades","author":"Hong","unstructured":"Hong AR, Lim JA, Kim TH, Choi HS, Yoo WS, Min HS, et al. The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades. Endocrinology and metabolism (Seoul, Korea).","journal-title":"Endocrinology and metabolism (Seoul, Korea)"},{"issue":"7","key":"key20230119065455_B6","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1210\/jc.2006-2707","article-title":"BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism","volume":"92","author":"Durante","year":"2007","unstructured":"Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab. 2007;92(7):2840-3.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20230119065455_B7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1210\/jc.2008-2390","article-title":"Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer","volume":"94","author":"Guan","year":"2009","unstructured":"Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2009;94(5):1612-7.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key20230119065455_B8","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/cam4.781","article-title":"Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries","volume":"5","author":"Vuong","year":"2016","unstructured":"Vuong HG, Kondo T, Oishi N, Nakazawa T, Mochizuki K, Inoue T, et al. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries. Cancer Med. 2016;5(8):1883-9.","journal-title":"Cancer Med"},{"issue":"22","key":"key20230119065455_B9","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/jnci\/djp354","article-title":"Papillary thyroid cancer incidence in the volcanic area of Sicily","volume":"101","author":"Pellegriti","year":"2009","unstructured":"Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. Journal of the National Cancer Institute. 2009;101(22):1575-83.","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"key20230119065455_B10","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer","volume":"99","author":"Liu","year":"2014","unstructured":"Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab. 2014;99(6):E1130-6.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20230119065455_B11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00268-017-4287-x","article-title":"Case-Control Study of Papillary Thyroid Carcinoma on Urinary and Dietary Iodine Status in South Korea","volume":"42","author":"Lee","year":"2018","unstructured":"Lee JH, Song RY, Yi JW, Yu HW, Kwon H, Kim SJ, et al. Case-Control Study of Papillary Thyroid Carcinoma on Urinary and Dietary Iodine Status in South Korea. World J Surg. 2018;42(5):1424-31.","journal-title":"World J Surg"},{"issue":"10","key":"key20230119065455_B12","first-page":"2690","article-title":"High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area","volume":"51","author":"Shi","year":"1991","unstructured":"Shi YF, Zou MJ, Schmidt H, Juhasz F, Stensky V, Robb D, et al. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res. 1991;51(10):2690-3.","journal-title":"Cancer Res"},{"issue":"43","key":"key20230119065455_B13","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1074\/jbc.272.43.27230","article-title":"Thyroid Na+\/I- symporter Mechanism, stoichiometry, and specificity","volume":"272","author":"Eskandari","year":"1997","unstructured":"Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N. Thyroid Na+\/I- symporter. Mechanism, stoichiometry, and specificity. J Biol Chem. 1997;272(43):27230-8.","journal-title":"J Biol Chem"},{"issue":"2","key":"key20230119065455_B14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0303-7207(97)00108-1","article-title":"Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+\/I- symporter mRNAs in dog thyroid","volume":"131","author":"Uyttersprot","year":"1997","unstructured":"Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, Dumont JE, et al. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+\/I- symporter mRNAs in dog thyroid. Mol Cell Endocrinol. 1997;131(2):195-203.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"key20230119065455_B15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/cncr.24118","article-title":"High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes","volume":"115","author":"Oler","year":"2009","unstructured":"Oler G, Cerutti JM. High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer. 2009;115(5):972-80.","journal-title":"Cancer"},{"issue":"1","key":"key20230119065455_B16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/erc.1.01119","article-title":"The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane","volume":"13","author":"Riesco-Eizaguirre","year":"2006","unstructured":"Riesco-Eizaguirre G, Gutierrez-Martinez P, Garcia-Cabezas MA, Nistal M, Santisteban P. The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane. Endocr Relat Cancer. 2006;13(1):257-69.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"key20230119065455_B17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-04-3314","article-title":"Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells","volume":"65","author":"Mitsutake","year":"2005","unstructured":"Mitsutake N, Knauf JA, Mitsutake S, Mesa C Jr, Zhang L, Fagin JA. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res. 2005;65(6):2465-73.","journal-title":"Cancer Res"},{"key":"key20230119065455_B18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.humpath.2018.04.023","article-title":"Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing","volume":"78","author":"Chang","year":"2018","unstructured":"Chang CC, Chang YS, Huang HY, Yeh KT, Liu TC, Chang JG. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing. Hum Pathol. 2018;78:151-8.","journal-title":"Hum Pathol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T12:51:47Z","timestamp":1674132707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/iodine-nutritional-status-is-not-a-direct-factor-in-the-prevalence-of-the-brafv600e-mutation-in-papillary-thyroid-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":18,"alternative-id":["10.20945\/2359-3997000000530"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000530","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}